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A synthetic methodology for accessing narrow-band, deep-red phosphorescence from 
mononuclear Pt(II) complexes is presented. These charge-neutral complexes have the general 
structure (N^N–^N)PtCl, in which the Pt(II) centers are supported by benzannulated diarylamido 
ligand scaffolds bearing substituted quinolinyl and/or phenanthridinyl arms. Emission maxima 
ranging from 683 to 745 nm are observed with lifetimes spanning from 850 to 4500 ns. In 
contrast to the corresponding proligands, benzannulation is found to counter-intuitively but 
markedly blue-shift emission from metal complexes with differing degrees of ligand 
benzannulation but similar substitution patterns. This effect can be further tuned by incorporation 
of electron-releasing (Me, tBu) or electron-withdrawing (CF3) substituents in either the 
phenanthridine 2-position or quinoline 6-position. Compared with symmetric bis(quinoline) and 
bis(phenanthridine) architectures, “mixed” ligands incorporating one quinoline and one 
phenanthridine unit present a degree of charge transfer between the N-heterocyclic arms that is 
more pronounced in the proligands than in the Pt(II) complexes. The impact of benzannulation 
and ring-substitution on the structure and photophysical properties of both the proligands and 





 Luminescent complexes that emit light in the deep red region of the electromagnetic 
spectrum are of interest for a variety of applications. For example, white light-emitting diode 
(LED) devices are commonly constructed by combining high purity red, green and blue emission 
into a broad spectral output.1 In addition, deep red and near infrared (NIR) light can penetrate 
biological tissue to a greater extent than shorter wavelengths and so is more compatible with 
bioimaging and sensing applications.2 While fluorescent deep red and NIR emitters have found 
application in luminescent devices and sensors,3 phosphorescent complexes present certain 
distinct advantages.4 In biosensing/imaging applications, for example, the longer lifetime of 
phosphorescence can avoid signal complications due to autofluorescence from endogenous 
fluorophores.5,6 In LED devices, phosphorescence can enable harvesting of excitons of both 
singlet and triplet multiplicity.7 
 Efficient, deep red molecular phosphors – emitting from triplet states – are not as common 
as the corresponding fluorescent emitters. Nevertheless, examples built on late transition metal 
ions are known for elements of Group 7 (Re8,9), Group 8 (Ru,10 Os11), Group 9 (Ir12,13), Group 10 
(Pt14–17) and Group 11 (Cu,18 Au19). As a third-row transition element, Pt has a large spin-orbit 
coupling (SOC) constant that boosts T1→S0 radiative decay, the formally forbidden 
phosphorescence process. In addition, the coordination chemistry of Pt is well-established.20 
Taken together, this has led to the design and use of platinum(II) complexes in phosphorescence-
based applications including light-emitting diodes,21–23 bioimaging,24–26 and chemosensing.27 The 
pursuit of deep red Pt(II) emitters is therefore of significant interest. Solution-state emission 
within this target wavelength region (~700 nm) has been extensively described for Pt(II) 
complexes with bimolecular excited states (e.g., aggregates or excimers).28,29 In comparison, 
complexes that can emit at these wavelengths from monomolecular excited states are very rare, 
as the extended conjugated systems required typically limit the available supporting ligand 
platforms to porphyrins or phthalocyanines.30–33 
 In addition to engineering bathochromically shifted emission with narrow profiles, intense 
absorption of the chromophore in the visible region can also be desirable, particularly in 
biological media where emissive probes and labels are ideally excited at wavelengths longer than 
those at which endogenous biological molecules strongly absorb.34,35 The “brightness” of a 
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phosphor, defined as the product of the extinction coefficient at the excitation wavelength and 
the emission quantum yield, is thus a critical parameter.24 Beyond imaging, in photodynamic 
therapy (PDT) too, triplet excited states with long enough lifetimes to sensitize singlet oxygen 
formation are advantageous.36 Designing molecules which combine strong absorption of visible 
light with efficient triplet excited-state formation and microsecond lifetimes is also attractive for 
accessing upconversion via triplet-triplet annihilation (TTA-UC).37 
 We recently reported a series of Pt(II) complexes that to date present some of the most red-
shifted phosphorescence for non-porphyrinic Pt(II) complexes emitting from monomolecular 
excited states.38 These complexes are based on anionic, tridentate pincer-like ligands, with the 
form (N^N–^N)PtCl. In this work, we extend our synthetic strategy and demonstrate how ligand 
substitution can be used to further tune the emission properties of a rare class of mononuclear 
Pt(II) deep red emitters. 
 
RESULTS AND DISCUSSION 
Ligand Preparation and Scope 
To build our library of ligands, functionalized amino/bromoquinolines and phenanthridines 
bearing either electron-withdrawing (EWG: CF3), electron-donating (EDG: CH3, tBu) groups, or 
no substituent (H) on the heterocycle were synthesized (Scheme 1). Phenanthridine precursors 
were prepared using tandem Pd-catalyzed cross-coupling/condensation reactions of 2-
formylphenylboronic acid and appropriately substituted anilines, following a protocol we 
previously established.39 Quinoline precursors were prepared using Skraup reaction conditions.40 
For the tricyclic systems, formation of the phenanthridine core was confirmed in each case by the 
appearance of a diagnostic proton resonance between 9.35 and 9.50 ppm, attributed to the N=CH 
in the 6-position of the heterocycle (Table S1).41 Once in hand, the amino- and bromo-substituted 
heterocycles were subjected to Buchwald-Hartwig amination conditions, similar to those 
reported for the synthesis of the bis(quinolinyl)amine L1H,H.42 In general, proligand synthesis 
proceeded efficiently and twelve bis(N-heterocyclic)amines with a variety of substitution 
patterns (grouped into L1R,R, L2R,R, L3R,R) were isolated in good yields (70-90%) as orange-red 
(L2Me,tBu) or yellow-green solids following chromatography. The L1R,R and L3R,R proligands are 
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bis(quinolyl)amines and bis(phenanthridinyl)amines respectively; superscripts are used to denote 
the substituents meta to the amine N–H. These proligands are symmetric around the N–H, apart 
from L3CF3,tBu which comprises two differently substituted phenanthridines. Within the L2R,R 
group, in contrast, each proligand contains one phenanthridine and one quinoline donor. 
 
 
Scheme 1. Synthetic routes to proligands (a) L1H,H 42 and L1Me,Me 38; (b) L2H,Me 43, L2H,tBu 44, 
L2H,CF3 44 (R1 = H, X = NH2; R2 = CF3, Y = Br; [Pd] = Pd2(dba)3, L = rac-BINAP);  L2Me,Me 38; 
L2Me,tBu (R1 = CH3, X = Br; R2 = tBu, Y = NH2; [Pd] = Pd2(dba)3, L = rac-BINAP), L2Me,CF3 (R1 
= CH3, X = NH2; R2 = CF3, Y = Br; [Pd] = Pd(OAc)2, L = dppf); (c) L3Me,Me 43, L3tBu,tBu, 
L3CF3,CF3, L3 tBu,CF3. The preparation and structures of their corresponding (N^N–^N)PtCl 
complexes 1R,R/2R,R/3R,R are also shown. The IUPAC numbering system for quinolines and 
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The proligands were characterized by 1H, 13C and 19F (for the CF3 derivatives) NMR 
spectroscopy in solution (see Table S1 for selected 1H NMR resonances). The crystal structure of 
a representative proligand (L3CF3,CF3) was obtained to verify the solution-state structure assigned 
by NMR (Figure 1). Appendage of two, 2-substituted phenanthridinyl rings about the central N–
H unit can be clearly seen in the solid state. The importance of the ‘imine-bridged biphenyl’ 
resonance contributor to the ground state of phenanthridine derivatives is evident in the 
comparably short C1-N1 [1.301(4) Å] and C15-N3 distances [1.301(3) Å]. Unlike related 
diarylamine proligands, L3CF3,CF3 is essentially flat in the solid state, likely a result of packing 
effects; π-stacking is evidenced by contacts of < 3.4 Å between neighboring phenanthridine units 
which are staggered head-to-tail relative to one another (Figure S1). 
 
Figure 1. Solid-state structure of L3CF3,CF3 with thermal ellipsoids at 50% probability and 
hydrogen atoms omitted for clarity. Selected bond distances (Å) and angles (°): N(1)–C(1) 
1.301(4), N(2)–C(10) 1.380(3), N(2)–C(24) 1.375(3), N(3)–C(15) 1.301(3); C(10)-N(2)-C(24) 
132.9(2). 
With the proligands in hand, a full library of Pt(II) complexes (series 1R,R, 2R,R, 3R,R from 
L1R,R, L2R,R, L3R,R) was prepared by reluxing dichloromethane solutions of proligand and 
Pt(COD)Cl2 (COD = 1,5-cyclooctadiene) in the presence of a base (sodium tert-butoxide). Over 
the course of the reaction, the complexes were observed to precipitate as dark red solids. They 
are all poorly soluble in common organic solvents, and solubility was further diminished by 
benzannulation despite the introduction of substituents such as tBu or CF3 onto the N-



































ligand binding, as the 6-positioned [CH] resonance of the phenanthridinyl arms of L2R,R and 
L3R,R shifted in a diagnostic fashion upon coordination (Table S1). When resolved, 3JPtH 
coupling constants of 33-39 Hz could be observed between the coordinated Pt and the hydrogen 
nucleus ortho to the donor nitrogen of the heterocyclic ligand. In this way, we were able to 
establish the structures of the library of compounds in solution. Compound purity in the solid-
state was confirmed using combustion analysis. 
The crystal structures of 2Me,tBu and 3tBu,tBu are shown in Figure 2. As with previously 
reported structures of 1H,H,42 1Me,Me,38 2H,Me and 3Me,Me,43 the coordinated ligands bind in a 
meridional fashion to each Pt center and form planar structures. The structure of 2Me,tBu does not 
contain any solvent molecules embedded in the crystal lattice, while that of 3tBu,tBu reveals a co-
crystallized equivalent of CH2Cl2. Close intermolecular π-π interactions (3.3-3.5 Å) can be 
discerned in the structure of 2Me,tBu (Figure S2); in that of 3tBu,tBu, they are replaced by non-
covalent interactions with co-crystallized CH2Cl2 solvent (Figure S3). The trend of decreasing 
solubility within the series 1R,R > 2R,R > 3R,R likely arises from the presence of π-π interactions 
similar to those seen in structure of 2Me,tBu, which are plausibly enhanced by benzannulation. 
Thus, crystals of 3tBu,tBu suitable for diffraction could only be grown through disruption of these 




Figure 2. Solid-state structures of (a) 2Me,tBu and (b) 3tBu,tBu with thermal ellipsoids at 50% 
probability and hydrogen atoms omitted for clarity. For each structure, views perpendicular to 
the metal square plane (top) and along the Cl–Pt–N(2) axis (bottom) are shown. Selected bond 
distances (Å) and angles (°) for 2Me,tBu: Cl(1)–Pt(1) 2.3307(6), N(1)–Pt(1) 1.9918(18), N(2)–
Pt(1) 1.9736(18), N(3)–Pt(1) 1.9950(19), N(1)–C(1) 1.314(3), N(3)–C(18) 1.336(3); N(1)-Pt(1)-
N(3)165.62(7), N(2)-Pt(1)-Cl(1) 178.55(5), N(1)-Pt(1)-Cl(1) 97.37(5), N(3)-Pt(1)-Cl(1) 
97.00(6), N(2)-Pt(1)-N(1) 83.06(7), N(2)-Pt(1)-N(3) 82.60(7), C(10)-N(2)-C(23) 131.27(18). 
3tBu,tBu: Cl(1)–Pt(1) 2.337(2), N(1)–Pt(1) 1.996(8), N(2)–Pt(1) 1.950(7), N(3)–Pt(1) 1.998(8), 
N(1)–C(1) 1.287(13), N(3)–C(17) 1.292(13); N(1)-Pt(1)-N(3) 165.9(3), N(2)-Pt(1)-Cl(1) 
179.4(3), N(1)-Pt(1)-Cl(1) 96.0(3), N(3)-Pt(1)-Cl(1) 98.1(3), N(2)-Pt(1)-N(1) 83.4(4), N(2)-































































Extension of a conjugated ligand’s π-system through benzannulation and introducing 
donor or acceptor substituents represent two common strategies for red-shifting emission from 
transition metal coordination complexes without introducing significant changes to the parent 
structure. Thompson and coworkers have shown that the structure-property relationship between 
benzannulation and absorption/emission, however, is more nuanced than is often supposed.45 In 
that study, they demonstrated that the effect of benzannulation must be evaluated in light of the 
site of benzannulation and the localization of the frontier orbitals for systems in which the lowest 
energy spin-allowed absorption and spin-forbidden emitting state involve HOMO-LUMO 
transitions. This new paradigm has been verified for 1,3-bis(2-pyridylimino)isoindoline-
supported platinum chlorides, various organic emitters,45 and phosphorescent cyclometallated 
Ir(III) complexes.46 For platinum chloride complexes supported by bis(8-quinolinyl)amido 
ligands (e.g., 1Me,Me), bis(phenanthridinyl)amido ligands (3Me,Me) and “mixed” analogues 
(2Me,Me) that incorporate one quinoline and one phenanthridine, however, we have discovered 
that this model does not fully hold.38 In these compounds, absorption and emission are not 
affected in the same way by benzannulation; all three complexes show isoenergetic absorption 
maxima, but emission from the complex with the most extended ligand π-system 3Me,Me is blue-
shifted by nearly 40 nm. Similarly exceptional behaviour was observed for phenanthridinyl and 
quinolinyl derivatives of (P^N)2CuX2 dimers.47 In that case, emission was shifted to higher 
energy for complexes of phenanthridinyl ligands despite a red-shift in absorption. The library of 
proligands presented here enables both further insight into the impact of π-extension and also 
how substitution patterns of benzannulated ligands affect absorption and emission. 
Proligands L1–L3 
The photophysical properties of the proligands are considered first, followed by those of 
the corresponding Pt(II) complexes. Table 1 compiles room temperature absorption and emission 
data in dichloromethane solution for all twelve proligands, with a selection of representative 
spectra shown in Figure 3 (absorption) and Figure 4 (emission). In our initial report,38 we 
considered only the dimethylated compounds L1Me,Me, L2Me,Me and L3Me,Me in order to isolate 
the effect of benzannulation by keeping ring substitution patterns consistent. All three proligands 
were found to show a strong, lowest energy absorption band centered around 400 nm. Although 
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this band appears to be shifted slightly to higher energy in the phenanthridine-containing systems 
L2R,R, L3R,R relative to the bis(quinoline) congener L1Me,Me in terms of the λmax value (Table 1, 
Figure 3), the former tail further into the visible and absorb more intensely at wavelengths 
greater than 415 nm. The first spin-allowed transition may thus be lower in energy for the 
phenanthridine-containing molecules which present more extended π systems, as would be 
anticipated based on the first singlet excited state energies of the constituent heterocycles (ES of 
quinoline and phenanthridine are 31850 and 28590 cm–1 respectively48). 
With the new proligand derivatives in hand, the effects of ring substitution can now be 
evaluated too. Considering the bis(phenanthridine) systems (L3R,R, Figure 3a), it can be seen that 
the replacement of the methyl substituents at the 2-position by electron-withdrawing 
trifluoromethyl groups leads to a blue-shift in the lowest energy absorption band, while changing 
to tBu substituents has little effect on λmax though the band is broadened slightly (Note: these 
shifts are best examined by referring to the spectra, rather than the λmax values which do not 
necessarily capture the full picture; see Figure S4). The band of the mixed-substituent L3CF3,tBu 
is also rather broad, but has a shorter λmax similar to L3CF3,CF3. These observations can be 
rationalized by considering the localization of the frontier orbitals. We previously demonstrated 
using density functional theory (DFT) and time-dependent DFT (TDDFT) calculations that the 
lowest energy transitions of L1Me,Me-L3Me,Me are HOMO→LUMO in nature.38 The HOMOs of 
these systems are comprised of the amine lone pair (:NH; ~20%) and the C6 ring of the 
heterocycle arms directly bonded to the amine unit (~34% from each arm). The LUMOs, in 
comparison, are made up of out-of-phase (π*) contributions from the π systems of the N-
heterocycles, specifically the C5N rings (~24% per N-heterocycle) and the C=N subunit in 
particular.38 Ring substitution at the 2-position of the phenanthridinyl rings in L3R,R most 
directly impacts the HOMO, being directly attached to the C6 ring comprising ~70% of this 
frontier orbital. Substitution with a strongly electron-withdrawing CF3 group has a stabilizing 
effect on the HOMO, widening the HOMO-LUMO gap, leading to the observed blue shift. CF3 
has a greater (electron-withdrawing) effect compared with the (electron-releasing) impact of tBu, 
as evidenced by the absolute values of their respective Hammett parameters (CF3: σmeta = 0.43; 




The “mixed” quinoline-phenanthridine systems L2R,R show a similar trend on variation of 
the phenanthridine substituent (Figure 3b), with the lowest energy absorption in L2Me,CF3 blue-
shifted relative to the dimethyl and tBu analogues. A strong band at around 310 nm – which is a 
feature of the bis(phenanthridine) L3R,R series but not of the bis(quinolines) L1R,R – also appears 
in the mixed L2R,R compounds but is proportionately weaker than in L3R,R, consistent with the 
presence of one of each type of heterocycle.38 The L2H,R compounds (with no substituent on the 
quinoline) show exactly the same trend (Figure S5), and there is no significant difference in their 
absorption spectra compared to their respective methylated quinoline analogs L2Me,R. 
 
 
Figure 3. UV-visible absorption spectra in CH2Cl2 solution at 295 K of (a) bis(phenanthridine) 
proligands L3R,R; (b) three of the mixed quinoline-phenanthridine L2Me,R (L2H,R are shown in 
Figure S5). In both panels, the absorption spectrum of the bis(quinoline) proligand L1Me,Me is 










































Table 1. Absorption and emission data of proligands in CH2Cl2 at 295 K and in EPA (diethyl 
ether/isopentane/ethanol, 2:2:1 v/v) glass at 77 K. 
Proligand Absorption 
λmax / nm  (ε  / M–1 cm–1) 
Emission 
λmax / nm 
Φ lum 
×  102 
Emission 77 K 
 λmax / nm  τ  / ns 
L1H,H 270 (23000), 342 (sh), 
403 (9520) 
475 0.35 429, 449 3.7 
L1Me,Me 269 (28400), 344 (3200), 
403 (9800) 
474 0.55 431, 451 3.5 
L2H,Me 254 (23900), 265 (23800), 310 
(6410), 395 (8910) 
497 0.16 445, 468 5.0 
L2H,tBu 254 (27700), 264 (27900), 309 
(7640), 397 (9320) 
493 0.23 437, 456 3.6 
L2H,CF3 255 (26800), 290 (6060), 309 
(4890), 386 (9050) 509 0.10 444, 467 2.2 
L2Me,Me 254 (26000), 264 (27100), 310 
(7400), 395 (9000) 
503 0.25 441, 461 3.8 
L2Me,tBu 255 (28200), 265 (29300), 311 
(7300), 394 (9480) 505 0.19 437, 455 3.4 
L2Me,CF3 257 (30200), 291 (6860), 310 
(5120), 386 (9140) 
518 0.12 445, 467 2.0 
L3Me,Me 253 (65200), 299 (22000), 308 
(sh), 388 (15900) 
485 0.20 447, 471 3.2 
L3tBu,tBu 253 (76100), 299 (26400), 309 
(sh), 383 (16500) 
498 0.47 443, 467, 
508, 551 
3.9 
L3CF3,CF3 247 (76000), 294 (20900), 304 
(sh), 382 (16100) 
476 0.098 423, 447 2.0 
L3CF3,tBu 254 (75400), 296 (21600), 
380 (16900) 
518 0.21 445, 469 3.8 
 
At room temperature, the twelve proligands all emit weakly in solution, with unstructured 
and broad fluorescence peaking at ~ 474–518 nm, quantum yields below 1% and lifetimes of less 
than 1 ns (Figure 4 and Table 1). We noted in our initial report38 how emission from the 
bis(quinoline) L1Me,Me occurs at higher energy than either of the phenanthridine-containing 
molecules. This trend is likewise observed in all of the new proligands reported here, consistent 
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Figure 4. Photoluminescence spectra in CH2Cl2 solution at 295 K of (a) bis(phenanthridine) 
proligands L3R,R; (b) three of the mixed quinoline-phenanthridine L2Me,R (L2H,R are shown in 
Figure S6). In both panels, the emission spectrum of the bis(quinoline) proligand L1Me,Me is 
provided for comparison. 
 
Amongst the three symmetrically substituted bis(phenanthridine) ligands, L3CF3,CF3 emits 
at highest energy and L3tBu,tBu the lowest (Figure 4a).  Interestingly, however, the asymmetric 
derivative L3CF3,tBu emits at unequivocally lower energy than either of them, indicative of an 










































similar observation is made for the L2R,R series: L2Me,CF3 emits at a lower energy than L2Me,Me 
or L2Me,tBu (Figure 4b), while L2H,CF3 emits at a lower energy compared to L2H,Me and L2H,tBu 
(Figure S6). Across the entire library, the mixed quinoline-phenanthridine compounds L2R,R are 
all red-shifted compared to their correspondingly substituted bis(phenanthridine) analogues 
L3R,R, consistent with the quinoline and phenanthridine units acting as donor and acceptor 
respectively in a charge-transfer process. At 77 K (Table 1, Figure S7), this effect is largely lost 
which may be understood in terms of a destabilization of the charge-transfer contribution under 
these conditions. Underscoring this point, the three compounds incorporating a methyl 
substituent in the 6-position of the quinoline arm (L2Me,R) all show a small but significant red-
shift relative to those with no substituent on the quinoline (L2H,R) at room temperature (Figure 
S8). This is consistent with the methylated quinoline being a slightly more electron-rich donor in 
the proposed charge-transfer process.  
 
Platinum complexes 
Photophysical data for all twelve of the platinum complexes are reported in Table 2, with 
selected UV-visible absorption spectra shown in Figure 5 (additional absorption and emission 
spectra are shown in Figures S9 and S10). The Pt complexes are all dark red in color. 
Accordingly, a broad and intense absorption band can be observed in each case, with a maximum 
at ~500 nm. Deprotonation of the amine N–H and chelation to a Lewis acidic Pt(II) center thus 
increases the energy of the highest occupied orbitals and concomitantly stabilizes the 
heterocycle-based π* orbitals, displacing the lowest energy absorption band by ~5000 cm–1 
compared with the proligands. The major difference between the phenanthridine-containing 
complexes (2R,R and 3R,R) and the bis(quinoline) analogs (1R,R) is the higher absorption of the 
former in the 300–350 nm region, as observed for the proligands. The identity of the substituents 
in the 2-position of the phenanthridine (or the 6-position of the quinoline)41 is seen to have 
minimal effect on the lowest-energy absorption band. As demonstrated for the methyl substituted 
analogs 1Me,Me-3Me,Me, the main contributor to the lowest energy absorption is the 
HOMO→LUMO+1 transition.38 Population analysis of both these orbitals revealed only small 
contributions of the carbon at the site of substitution. For example, there is no orbital density 
present at the carbons directly bonded to the methyl groups, nor at the methyl groups themselves, 
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in the HOMOs of 1Me,Me-3Me,Me. Thus, only the bis-CF3-substituted complex, bearing strongly 
electron-withdrawing substituents, shows some differences in relative intensities of UV and 
visible bands compared to the others (Figure 5a). Nevertheless, only a small shift to lower energy 
is observed for the lowest energy absorption in 3CF3,CF3 compared with 3Me,Me. 
 
Table 2. Absorption and emission data of Pt(II) complexes[a]  






×  102 
[b,c] 
 
τ / ns 












/ 109  
M–1s–1 [f] 
Emission 77 K[g] 
 
λmax / nm 
[h] 
τ / ns 
1H,H 239, 300, 342, 
357, 381, 504 740 0.10 
1200 
[170] 0.83 8.3 2.3 692, 760 3300 
1Me,Me 240, 301, 340, 
356, 381, 501 738 0.081 
1800 
[230] 0.49 5.6 1.7 696, 763 2200 
2H,Me 244, 258, 284, 
315, 338, 353, 
404, 504 
745 0.11 1100 [180] 1.0 9.1 2.1 692,753 5200 
2H,tBu 245, 260, 280sh, 
317, 338, 356, 
403, 508 
737 0.22 1800 [190] 1.2 5.5 2.1 682,741 2900 
2H,CF3 235, 261, 283, 
325, 356, 412, 
500 
712 0.31 2000 [250] 1.6 5.0 1.6 680, 726 6500 
2Me,Me 246, 284, 315, 
338, 354, 405, 
502 
740 0.13 1000 [180] 1.3 10 2.1 692, 756 3000 
2Me,tBu 243, 285, 316, 
338, 355, 405, 
505 
743 0.092 850 [220] 1.1 12 1.5 690, 753 5600 
2Me,CF3 236, 261, 282, 
324, 356, 415, 
497, 570sh 
710 0.30 2000 [210] 1.5 5.0 1.9 711, 774 2600 
3Me,Me 265, 321, 338, 
355, 405, 503 703 0.18 
2500 
[190] 0.72 4.0 2.2 663, 727 18300 
3tBu,tBu 266, 324, 338, 
356, 406, 509 713 0.47 
2000 
[190] 2.4 5.0 2.2 664, 728 2600 
3CF3,CF3 241, 263, 330, 
348, 369, 404sh, 
506, 539sh 
683 0.10 4500 [240] 0.22 2.2 1.8 675 1800 
3CF3,tBu 265, 325, 337, 
356, 399, 502, 
570sh 
715 0.30 1300 [240] 2.3 7.7 1.5 702 2300 
[a] In degassed CH2Cl2 at 295 K, except where indicated otherwise. [b] Emission maxima and photoluminescence 
quantum yields Φlum determined from spectra recorded using a Synapse CCD detector. [c] Measured in deoxygenated 
solution, using [Ru(bpy)3]Cl2(aq) as the standard. [d] Luminescence lifetimes in deoxygenated solution.  Values in air-
equilibrated solution are given in square parenthesis. [e] Radiative (kr) and non-radiative (Σknr) rate constants 
estimated from quantum yield and lifetime, assuming unitary population of the emissive state upon light absorption:  
kr ∼ Φ / τ; knr ∼ (1–Φ) / τ. [f] Bimolecular Stern-Volmer constant for quenching by molecular oxygen, estimated from 
the lifetimes in deoxygenated and air-equilibrated solution, and assuming [O2] = 2.2 mmol dm–3 at atmospheric 
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pressure of air. [g] In diethyl ether / isopentane / ethanol (2:2:1 v/v). [h] Emission spectra at 77 K were recorded using 




Figure 5. UV-visible absorption spectra in CH2Cl2 solution at 295 K of (a) bis(phenanthridine) 
series 3R,R; (b) three of the mixed quinoline-phenanthridine series 2Me,R (2H,R are shown in 
Figure S9). In both panels, the absorption spectrum of the bis(quinoline) complex 1Me,Me is 
provided for comparison. 
 
DFT modeling of 3CF3,CF3 is consistent with this observation (Figure 6). Namely, the 
introduction of strongly electron-withdrawing CF3 groups has a stabilizing influence on both the 
HOMO of 3CF3,CF3 (EHOMO = -5.74 eV) compared to 3Me,Me (EHOMO = -5.29 eV; ΔEHOMO = -0.45 








































0.48 eV). As for 1Me,Me/2Me,Me/3Me,Me,38 TDDFT reveals the lowest energy absorption in 3CF3,CF3 
is dominated by the HOMO→LUMO+1 transition (Table S2, Figure S11). Interestingly, a 
consequence of the introduction of a strongly electron-withdrawing CF3 substituent in 2Me,CF3 is 
to turn on the HOMO→LUMO transition, which is predicted by TDDFT to have an oscillator 
strength comparable to that of the HOMO→LUMO+1 transition and thus contribute to the 
lowest energy absorption band (Table S3, Figure S12). Indeed, it appears as a low-energy 
shoulder in the UV-Vis absorption spectrum (Figure 5). Consequently, the broad, lowest energy 
absorption band for 2Me,CF3 is not significantly shifted compared to the rest of the 2R,R series. 
Despite a larger HOMO-LUMO+1 energy gap, the participation of the lower energy 
HOMO→LUMO transition keeps the absorption maximum relatively unchanged. 
 
Figure 6. Selected MOs and energies (IEFPCM[CH2Cl2]-M06/LANL2DZ; isosurface = 0.05) of 
2Me,CF3 and 3CF3,CF3. 
The location of the CF3 substituent on the phenanthridinyl arm in 2Me,CF3 has an unequal 
effect on the HOMO, LUMO and LUMO+1. Specifically, the electron-withdrawing effect of CF3 
results in relatively significant stabilization of both the HOMO and LUMO compared to in 
2Me,Me  but has less of an impact on the acceptor LUMO+1. The influence on the HOMO can be 





























mixed quin/phen systems 2R,R, the LUMO and LUMO+1 are comprised of different relative 
contributions from the quinolinyl and phenanthridinyl arms. In 2Me,Me, the quinolinyl moiety 
contributes more than the phenanthridinyl unit does to the LUMO+1 and vice versa for the 
LUMO.38 Introducing a CF3 substituent exaggerates this asymmetry, such that the 
phenanthridinyl arm completely dominates the LUMO in 2Me,CF3 (see Tables S4 and S5 for 
population analysis). Thus, the LUMO energy is most drastically impacted by introduction of a 
strongly electron-withdrawing CF3 substituent; the LUMO+1, less so. In pseudooctahedral Fe(II) 
complexes of L2H,CF3 and L2H,tBu, introduction of a strongly electron-withdrawing CF3 at the 
phenanthridine was found to similarly increase the phenanthridine contributions to the LUMO 
over those from quinoline.44 This contrasts with what is often observed for CF3-containing 
luminescent organometallics (e.g., those based on cyclometallating ligands) where, although both 
HOMO and LUMO are stabilized, the latter is more so, largely inducing bathochromic shifts.51,52 
Structure-property relationships accounting for the placement of substituents relative to the 
primary orbital density comprising the HOMO and LUMO have been previously used to explain 
unequal impacts on the frontier orbitals in cyclometallated Ir emitters.49 It is notable that λmax for 
2Me,CF3 is still some 27 nm red-shifted compared to 3CF3,CF3, which has no quinoline unit. 
All twelve platinum complexes are emissive at room temperature in deoxygenated 
solution, with luminescence in the deep red/NIR that tails to 800–1000 nm (Figure 7, Figure S9; 
Table 2). Owing to the poor sensitivity of conventional photomultiplier tubes in this region, the 
spectra shown in Figure 7 were recorded using a CCD detector with superior sensitivity in the 
NIR (see Experimental Section for details). Each spectrum contains a relatively narrow, 
unstructured band (FWHM ~ 2300 cm–1). In our initial study of the parent dimethyl complexes, 
we noted how emission from the bis(phenanthridine) complex 3Me,Me is unequivocally higher in 
energy compared to that of the quinoline-containing complexes 1Me,Me and 2Me,Me, in spite of the 
greater conjugation of the phenanthridinyl-containing ligands.38 We traced this to enhanced 
rigidity within the benzannulated phenanthridinyl systems, which results in a higher energy 
emissive triplet state. The “mixed” system 2Me,Me behaves like the bis(quinoline) 1Me,Me, 





Figure 7. Photoluminescence spectra in CH2Cl2 at 295 K of (a) the bis(phenanthridine) series 
3R,R;  (b) three mixed quinoline-phenanthridine 2Me,R complexes (2H,R are shown in Figure S9). 
In both panels, the emission spectrum of the bis(quinoline) complex 1Me,Me is provided for 
comparison. 
 
These observations are largely borne out amongst the new series of complexes, with most 
of the quinoline-containing compounds (1R,R and 2R,R) emitting at lower energy than the 
bis(phenanthridines) 3R,R. Within the series of substituted bis(phenanthridine) complexes, it can 
be seen that the substituents have a small but noticeable influence on λmax (Figure 7a). The trend 
parallels that observed in the proligands. Namely, a blue shift is observed on going from the bis-
CH3 3Me,Me to bis-CF3-substituted complex 3CF3,CF3, while a red shift results from introduction of 
tBu groups in 3CF3,tBu and 3tBu,tBu. As noted above, the introduction of strongly electron-









































withdrawing CF3 substituents in 3CF3,CF3 stabilizes both the HOMO and LUMO+1 by similar 
amounts (ΔEHOMO = -0.45 eV; ΔELUMO+1 = -0.48 eV). In comparison, the LUMO is stabilized by a 
smaller amount (ΔELUMO = -0.39 eV). This has an overall destabilizing effect on the lowest-lying 
emissive state [E(T1) = 2.03 eV; Table S6], which is thus less stabilized than the T1 state of 
3Me,Me [E(T1) = 1.88 eV]38 resulting in blue-shifted emission despite slightly red-shifted 
absorption. As for 3Me,Me, optimization of the T1 structure of 3CF3,CF3 reveals the most significant 
excited state distortions in the lowest-lying T1 state are localized in the phenanthridinyl ligand 
arms; the coordination environment about the Pt center is left largely untouched (Table S7, 
Figure S13). 
The “mixed” complexes in series 2R,R, in comparison, reveal a different picture. Those 
incorporating methyl or tBu substituents in the phenanthridine emit at similar energy to the 
parent 2Me,Me and 2H,Me, consistent the emissive excited state involving the quinoline (rather than 
the phenanthridine). However, emission from both 2Me,CF3 and 2H,CF3 is blue-shifted by ~30 nm 
relative to the rest of the 2R,R series, rendering their emission maxima similar to those of some of 
the bis(phenanthridines) and apparently counteracting the red-shifting effect of the quinoline. 
Comparing the optimized structures of the T1 and ground state (S0) of 2Me,CF3, the most 
significant distortions are in fact localized in the C5N rings of the phenanthridinyl ligand arm 
(Figure S13). Thus, unlike for 1R,R and 2R,R, inclusion of strongly electron-withdrawing 
substituents leads to emissive excited states in the CF3-substituted analogs with stronger 
participation of the phenanthridine rather than the quinoline. A plot of the spin density in the 
lowest lying T1 state (Figure S14) supports this assertion and confirms the 3MLCT character of 
the lowest lying triplet excited states for both 2Me,CF3 and 3CF3,CF3. The higher energy emission 
from 2R,CF3 can be traced to a higher energy T1 state [E(T1, 2Me,CF3) = 1.79 eV vs E(T1, 2Me,Me) = 
1.77 eV38]. 
In deoxygenated solutions, the observed excited-state lifetimes are on the order of a 
microsecond, typical of cyclometallated Pt(II) complexes (Table 2). These values are consistent 
with formally spin-forbidden phosphorescence from a triplet excited state, expedited by the spin-
orbit coupling of the heavy metal. In air-equilibrated solutions, the lifetimes are shorter by an 
order of magnitude. The triplet excited state is quenched by molecular oxygen with bimolecular 
rate constants of ~2 × 109 M–1 s–1. The quantum yields are all low, in the range of 0.1–0.5%. 
Interestingly, the complexes that display the brightest emission do not have the longest lifetimes, 
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suggesting that structural variation influences both radiative kr and non-radiative knr rate 
constants. Assuming that the emitting state is formed with unit efficiency, these rate constants 
can be estimated using the expressions kr = Φ / τ and knr = (τ–1 – kr). Considering first the knr 
values, it can be seen that the highest values are found for the complexes that emit at lowest 
energy and vice versa, as predicted by the “energy gap law”. This trend is expected in the 
absence of deactivation processes involving higher-lying states for compounds that present a 
common type of excited state, as intramolecular energy transfer into vibrational modes becomes 
increasingly probable.53 Previous studies of Ru(II) and Pt(II) complexes54–56 revealed a 
logarithmic dependence. Here, a fairly convincing linear relationship can be seen in a plot of 
ln(knr) versus the excited-state energy (which we estimate from λmax), when considering the 
twelve complexes collectively (Figure 8). Inevitably, additional factors may be introduced when 




Figure 8. Plot of ln(knr) versus the emission energy, estimated from λmax,em in degassed CH2Cl2 
at 295 K. Data points for the bis(quinoline) complexes (1R,R; orange circles), bis(phenanthridine) 
series (3R,R; black squares) and the mixed quinoline-phenanthridine series (2R,R; purple 
diamonds) are shown along with the best linear fit using all data points (dashed green line). 
 
On the other hand, there is no obvious trend in kr.  However, it can be seen that kr is smallest for 
the highest-energy emitters 3CF3,CF3 and it is evidently for this reason that its quantum yield is not 
the highest amongst the series, despite having the lowest knr value. In contrast, the highest 
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magnitude larger (e.g., for 3CF3,CF3 and 3tBu,tBu, the kr values are 220 and 2400 s–1 respectively). 
Since kr for the formally forbidden phosphorescence process is determined by the efficiency of 
spin-orbit coupling, which in turn is dependent on the degree of metal character in the excited 
state, these observations might suggest a better matching of orbital energies of ligand and metal 
when electron-donating substituents are present. The efficiency of spin-orbit coupling is also 
inversely dependent on the S1–T1 energy gap, and so it is possible that this gap is smallest in 
3tBu,tBu and 3CF3,tBu. 
 Although the quantum yields are low, such values are quite typical for NIR-
phosphorescent complexes of many transition metals in solution where the combined effects of 
fast non-radiative decay and a low degree of metal participation in the excited state conspire to 
limit efficiency.4,57 The best reported performance for Pt(II) systems is offered by complexes of 
highly conjugated benzoporphyrins, where quantum yields in excess of 50% have been 
observed,4,58 but their synthesis is often demanding, with poor solubility and marked propensity 
to aggregation. In OLED devices, the use of bimolecular excited states formed through 
interfacial intermolecular interactions between Pt(II) complexes offers an alternative way of 
achieving efficient NIR emission,23,29 but some of the best performing OLED emitters of this 
type are actually non-emissive in solution.59 Notable features of the Pt(II) complexes reported 
here are the relatively narrow spectra (2300 cm–1 compared to > 3000 cm–1 for some excimer-
based systems28,29) and the sharp onset of emission on the high-energy side of the spectrum. This 
latter property limits or even eliminates contamination of the spectrum by visible emission, a 
requirement in some applications of NIR OLEDs. 
 
CONCLUSION 
In conclusion, we present here a synthetic methodology based on chelating, pincer-like 
benzannulated diarylamido ligand scaffolds for constructing phosphorescent Pt(II) complexes 
which emit in the deep red region of the electromagnetic spectrum with narrow band profiles.  
The construction of 2-substituted phenanthridines amenable to cross-coupling conditions enables 
the preparation of a wide library of compounds, with varying substituents, as in the L2R,R and 
L3R,R series of proligands and platinum complexes 2R,R and 3R,R. Benzannulation, counter-
intuitively but markedly, blue-shifts emission in this series, attributable to an increase in 
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molecular rigidity and the ability of the phenanthridine (3,4-benzoquinoline) units to buffer 
against substantial molecular reorganization.38 The influence of substituents in the 
phenanthridine 2-position can further be used to modulate the photophysical properties 
dependent on the relative strength of the substituent as an electron donating/accepting group. 
This influence therefore is subtle for substituents with lower Hammett parameters (Me, tBu) 
compared to those with larger ones (CF3).50 Overall, the impact of CF3 substituents is most 
pronounced, leading to significant hypsochromic shifts to emission, to such an extent that the 
2Me,CF3 and 2H,CF3 complexes emit at higher energy than the bis(quinolines) 1Me,Me and 1H,H. This 
influence is traced to unequal impacts of the substituent on the HOMO and LUMO+1, which 
represent the donor and acceptor orbitals involved in formation of the lowest energy excited 
state. The phosphorescence radiative rate constants of the complexes are mostly in excess of 
103 s–1 but are reduced in the highest-energy emitters, possibly due to mismatching of metal and 
ligand orbitals and hence inefficient spin-orbit coupling. The non-radiative rate constants, 
meanwhile, show a trend that is in line with that expected from the energy gap law, with the 
lowest-energy emitters subject to the most rapid non-radiative decay. Efforts to improve deep red 
phosphorescence further by addressing the relative rates of radiative vs. non-radiative decay 




Air-sensitive manipulations were performed in either a N2-filled glove box or using standard 
Schlenk techniques in argon atmosphere. Pd2(dba)3, Pd(PPh3)4, Pd(OAc)2, (±)-2,2′-
bis(diphenylphosphino)-1,1′-binaphthalene (rac-BINAP), 1,1'-bis(diphenylphosphino)ferrocene 
(dppf), sodium tert-amoxide (NaOtAm) and sodium tert-butoxide (NaOtBu) were purchased  
(Sigma Aldrich) and used without further purification. 8-Bromo-6-methylquinoline,40 8-amino-6-
methylquinoline,61 4-amino-2-trifluoromethylphenanthridine,62 Pt(COD)Cl2,63 4-amino-2-
methylphenanthridine, L1Me,Me, L2Me,Me, 1Me,Me and 2Me,Me,38 L3Me,Me and 3Me,Me,43 L2H,tBu and 
L2H,CF3 44 were synthesized according to literature procedures. Organic solvents were dried and 
distilled using appropriate drying agents, and distilled water was degassed prior to use. 1- and 2D 
NMR spectra were recorded on Bruker Avance 300 MHz or Bruker Avance–III 500 MHz 
spectrometers. All 1H and 13C{1H} NMR spectra were referenced to residual solvent peaks. 19F 
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NMR spectra were collected using deuterated solvents and locked to the deuterium signal. NMR 
spectra of all new compounds are provided in Figures S15-S39. Elemental analyses were 
performed by Microanalytical Service Ltd., Delta, BC (Canada), and at the University of 
Manitoba using a Perkin Elmer 2400 Series II CHNS/O Elemental Analyzer. 
Synthesis of Ligand Precursors 
4-bromo-2-tert-butylphenanthridine: A 500 mL Teflon-stoppered flask was charged with 
Pd(PPh3)4 (1.66 g, 1.43 mmol) and 50 mL of 1,2-dimethoxyethane (DME). After stirring briefly 
to mix, 2-bromo-6-iodo-4-tert-butyl-toluidine (15.02 g, 47.80 mmol), 2-formylphenylboronic 
acid (7.89 g, 52.58 mmol) and an additional 70 mL of DME were added, followed by Na2CO3 
(15.20 g, 143.4 mmol) dissolved in 100 mL of degassed water. The flask was then sealed, and 
the mixture stirred vigorously for 6 h in an oil bath (130 °C). The flask was then allowed to cool, 
HCl(aq) (2 M, 130 mL) added, and the mixture refluxed for additional 2 h. The flask was then 
cooled, neutralized with NaOH, and pumped to dryness. The residue was taken up in CH2Cl2 
(100 mL) and washed with brine (3 × 100 mL). The organic layer was separated, dried over 
Na2SO4 and volatiles removed to leave a yellow-brown solid. Column chromatography on basic 
alumina gave a pale-yellow solid (Rf = 0.41; 1:5 EtOAc/hexane). Isolated yield = 11.74 g (86 
%). 1H NMR (CDCl3, 500 MHz, 22 °C): δ 9.33 (s, 1H; CArH), 8.62 (d, 1H, JHH = 8.4 Hz; CArH), 
8.52 (s, 1H; CArH), 8.14 (d, 1H, JHH = 1.9 Hz; CArH), 8.06 (d, 1H, JHH = 7.9 Hz; CArH), 7.87 (t, 
1H, JHH = 7.6 Hz; CArH), 7.71 (t, 1H, JHH = 7.4 Hz; CArH), 1.49 ppm (s, 9H; tBu). 13C{1H} NMR 
(CDCl3, 125 MHz, 22 °C): δ 153.8 (CAr), 150.9 (CAr), 140.0 (CAr), 132.6 (CAr), 131.3 (CAr), 
131.1 (CAr), 129.1 (CAr), 128.0 (CAr), 126.6 (CAr), 125.5 (CAr), 125.3 (CAr), 122.0 (CAr), 117.8 
(CAr), 35.4 (CCH3)3, 31.5 ppm (CH3). 
General Procedure for Proligand Synthesis (L1-L3): 
A thick-walled, 100 mL Teflon-stoppered flask was charged with a Pd catalyst, ligand (rac-
BINAP or dppf) and toluene (30 mL) in the amounts noted below. After stirring briefly, the 
appropriate quinoline or phenanthridine reagents were added, along with an additional 30 mL of 
toluene, followed by the alkoxide base. The sealed flask was then stirred vigorously for 72 h in 
an oil bath set to 150 °C. After cooling and removing the volatiles, the residue was taken up in 
CH2Cl2 (120 mL) with the resulting suspension filtered over Celite and dried. 
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L2Me,tBu: The general procedure was followed using: Pd2(dba)3 (0.110 mg, 0.120 mmol), rac-
BINAP (0.162 g, 0.440 mmol); 8-bromo-6-methylquinoline (0.490 g, 2.20 mmol), 4-amino-2-
tert-butylphenanthridine (0.500 g, 2.00 mmol); and NaOtAm (0.29 g, 3.0 mmol). Column 
chromatography gave an orange-red solid (neutral alumina; 1:5 EtOAc/hexane; Rf = 0.43). 
Isolated yield = 1.01 g (92%). 1H NMR (CDCl3, 300 MHz, 22 °C): δ 10.43 (br s, 1H; NH), 9.29 
(s, 1H; CArH), 8.91 (dd, 1H, JHH = 4.2, 1.7 Hz; CArH), 8.68 (d, 1H, JHH = 8.2; CArH), 8.19-8.02 
(m, 4H; CArH), 7.91-7.82 (m, 1H; CArH), 7.77 (d, 1H, JHH = 1.6 Hz; CArH), 7.70 (dd, 1H, JHH = 
8.0, 7.0 Hz; CArH), 7.46-7.39 (m, 1H; CArH), 7.11 (br s, 1H; CArH), 2.57 (s, 3H; CH3), 1.57 (s, 
9H, C(CH3)3 ppm. 13C{1H} NMR (CDCl3, 75 MHz, 22 °C): δ 150.6 (CAr), 150.4 (CAr), 147.3 
(CAr), 139.2 (CAr), 139.0 (CAr), 137.0 (CAr), 135.5 (CAr), 133.1 (CAr), 130.7 (CAr), 129.2 (CAr), 
128.9 (CAr), 127.3 (CAr), 127.0 (CAr), 124.3 (CAr), 122.4 (CAr), 121.8 (CAr), 116.7 (CAr), 111.6 
(CAr), 110.9 (CAr), 108.8 (CAr), 35.7(C(CH3)3), 31.7 (PhenCH3), 22.7 (QuinCH3) ppm. 
L2Me,CF3: The general procedure was followed using: Pd(OAc)2 (0.025 g, 0.11 mmol), dppf 
(0.086 g, 0.15 mmol); 4-bromo-2-trifluoromethylphenanthridine (0.710 g, 2.18 mmol), 8-amino-
6-methylquinoline (0.350 g, 2.23 mmol); and NaOtAm (0.35 g, 3.27 mmol). Column 
chromatography gave a yellow-green solid (neutral alumina; 1:5 EtOAc/hexane; Rf = 0.3). 
Isolated yield = 0.77 g (88%). 1H NMR (CDCl3, 300 MHz, 22 °C): δ 10.74 (br s, 1H; NH), 9.43 
(s, 1H; CArH), 8.90 (dd, 1H, JHH = 4.1, 1.7 Hz; CArH), 8.65 (d, 1H, JHH = 8.5 Hz; CArH), 8.32 (s, 
1H; CArH), 8.18-8.04 (overlapped m, 3H; CArH), 7.93 (dd, JHH = 8.4, 7.1 Hz; 1H, CArH), 7.83-
7.73 (overlapped m, 2H; CArH), 7.45 (dd, 1H, JHH = 8.3, 4.2 Hz; CArH), 7.23-7.14 (br s, 1H; 
CArH), 2.60 ppm (s, 3H; QuinCH3). 13C{1H} NMR (CDCl3, 75 MHz, 22 °C): δ 153.0 (CAr), 147.6 
(CAr), 140.7 (CAr), 139.1 (CAr), 137.9 (CAr), 137.2 (CAr), 136.4 (CAr), 135.6 (CAr), 132.9 (CAr), 
131.6 (CAr), 131.0 (q, CAr), 129.6 (CAr), 129.20 (CAr), 129.16 (CAr), 128.3 (CAr), 127.1 (CAr), 
124.5 (CAr), 122.6 (CAr),122.0 (CAr), 118.2 (CAr), 113.1 (CAr), 109.6 (q, CAr), 106.0 (q, CAr), 22.6 
ppm (QuinCH3). 19F{1H} NMR (CDCl3, 282 MHz, 22 °C): δ -62.26 ppm. 
L3tBu,tBu: The general procedure was followed using: Pd(OAc)2 (0.032 g, 0.14 mmol); dppf (0.13 
g, 0.23 mmol); 4-bromo-2-tert-butylphenanthridine (0.90 g, 2.9 mmol); 4-amino-2-tert-
butylphenanthridine (0.70 g, 3.2 mmol); and NaOtAm (0.45 g, 4.3 mmol). Column 
chromatography gave a yellow-green solid (neutral alumina; 1:5 EtOAc/hexane; Rf = 0.35). 
Isolated yield = 1.08 g (78%). 1H NMR (CDCl3, 300 MHz, 22 °C): δ 10.41 (br s, 1H; NH), 9.30 
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(s, 2H; CArH), 8.69 (d, 2H, JHH = 8.4 Hz; CArH), 8.18 (s, 2H; CArH), 8.14-8.05 (overlapped m, 
4H; CArH), 7.91-7.82 (m, 2H; CArH), 7.76 (m, 2H; CArH), 1.55 ppm (s, 18H; C(CH3)3). 13C{1H} 
NMR (CDCl3, 75 MHz, 22 °C): δ 150.54 (CAr), 150.50 (CAr), 139.7 (CAr), 134.0 (CAr), 133.2 
(CAr), 130.7 (CAr), 128.9 (CAr), 127.3 (CAr), 127.1 (CAr), 124.4 (CAr), 122.4 (CAr), 110.0 (CAr), 
108.5 (CAr), 35.7 (C(CH3)3), 31.8 ppm (C(CH3)3). 
L3CF3,CF3: The general procedure was followed using: Pd(OAc)2 (21.0 mg, 0.09 mmol); dppf 
(72.0 mg, 0.13 mmol); 4-bromo-trifluoromethylphenanthridine (0.65 g, 1.99 mmol); 4-amino-2-
trifluoromethylphenanthridine (0.53 g, 2.33 mmol); and NaOtAm (0.29 g, 2.78 mmol). Column 
chromatography gave a yellow-green solid (neutral alumina; 1:5 EtOAc/hexane; Rf = 0.2). 
Isolated yield = 0.76 g (74%). 1H NMR (CDCl3, 500 MHz, 22 °C): δ 10.91 (br s, 1H, N-H), 9.42 
(s, 2H, CArH), 8.63 (d, 2H, JHH = 8.1 Hz, CArH), 8.34 (s, 2H, CArH), 8.20-8.08 (overlapped m, 
4H, CArH), 7.94 (app t, JHH = 7.4 Hz, 2H, CArH), 7.83 ppm (app t, 2H, JHH = 7.3 Hz, CArH). 
13C{1H} NMR (CDCl3, 125 MHz, 22 °C): δ 153.3 (CAr), 140.0 (CAr), 136.5 (CAr), 132.8 (CAr), 
131.8 (CAr), 129.23 (CAr), 129.19 (CAr), 128.5 (CAr), 128.4 (CAr), 127.1 (CAr), 124.7 (CAr), 122.6 
(CAr), 110.7 (CAr), 106.7 ppm (CAr). 19F{1H} NMR (CDCl3, 470 MHz): δ -62.45 ppm. 
L3CF3,tBu: The general procedure was followed using: Pd(OAc)2 (0.025 g, 0.11 mmol), dppf 
(0.083 g, 0.15 mmol); 4-bromo-2-trifluoromethylphenanthridine (0.70 g, 2.2 mmol); 4-amino-2-
tert-butylphenanthridine (0.55 g, 2.2 mmol); and NaOtAm (0.34 g, 3.2 mmol). Column 
chromatography gave a yellow-green solid (neutral alumina; 1:5 EtOAc/hexane; Rf = 0.32). 
Isolated yield = 0.89 g (83%) 1H NMR (CDCl3, 300 MHz, 22 °C): δ 10.57 (br s, 1H; NH), 9.43 
(s, 1H; CArH), 9.30 (s, 1H; CArH), 8.67 (dd, 2H, JHH = 11.7, 8.3 Hz; CArH), 8.29 (s, 1H; CArH), 
8.22-8.04 (m, 5H; CArH), 7.97-7.85 (m, 2H; CArH), 7.82-7.70 (m, 2H; CArH), 1.56 ppm (s, 9H; 
C(CH3)3). 13C{1H} NMR (CDCl3, 75 MHz, 22 °C): δ 152.9 (CAr), 151.0 (CAr), 150.6 (CAr), 141.2 
(CAr), 138.5 (CAr), 136.3 (CAr), 134.3 (CAr), 133.1 (CAr), 132.9 (CAr), 131.6 (CAr), 130.9 (CAr), 
129.6 (CAr), 129.2 (CAr), 129.2 (CAr), 129.0 (CAr), 128.3 (CAr), 127.5 (CAr), 127.1 (CAr), 127.1 
(CAr), 124.7 (CAr), 124.5 (CAr), 122.6 (CAr), 122.4 (CAr), 111.7 (CAr), 110.0 (CAr), 109.2 (q, CAr), 
105.8 (q, CAr), 35.7 (C(CH3)3), 31.6 ppm (C(CH3)3). 19F{1H} NMR (CDCl3, 282 MHz, 22 °C): δ 
-62.52 ppm. 
General Procedure for Pt Complex Synthesis: In a thick-walled Teflon-stoppered flask, 
equimolar amounts of Pt(COD)Cl2 and NaOtBu were added to a solution of the appropriate 
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ligand (L1R,R, L2R,R or L3R,R) in CH2Cl2 (10 mL), and the mixture stirred vigorously in an oil 
bath set to 70 °C for 18 h. The resulting red suspension was allowed to cool, and the volatiles 
were removed in vacuo. The residue was then washed with acetonitrile (3 × 10 mL) and 
diethylether (3 × 10 mL). 
2H,tBu: The general procedure was followed using: L2H,tBu (0.20 g, 0.53 mmol),  Pt(COD)Cl2 
(0.20 g, 0.54 mmol), and NaOtBu (0.050 g, 0.54 mmol). Isolated yield = 0.279 g (87%). 1H 
NMR (CDCl3, 300 MHz, 22 °C): δ 9.60 (s, 1H, 3JPtH = 39 Hz, CArH), 9.25 (d, 1H, JHH = 5.0 Hz; 
CArH), 8.58 (d, 1H, JHH = 8.4 Hz; CArH), 8.27 (d, 1H, JHH = 8.2 Hz; CArH), 8.09 (d, 1H, JHH = 8.0 
Hz; CArH), 8.03-7.85 (overlapped m, 2H, CArH), 7.80 (s, 1H, CArH), 7.76-7.68 (overlapped m, 
2H, CArH), 7.53 (app t, 1H, JHH = 8.0 Hz; CArH), 7.41 (dd, 1H, JHH = 8.3, 5.0 Hz; CArH), 7.06 (d, 
1H, JHH = 7.9 Hz; CArH), 1.57 ppm (s, 9H, CH3). Anal. Calcd for C26H22ClN3Pt: C, 51.45; H, 
3.65. Found: C, 51.15; H, 3.74.  
2H,CF3: The general procedure was followed using: L2H,CF3 (0.10 g, 0.26 mmol),  Pt(COD)Cl2 
(0.096 g, 0.26 mmol), and NaOtBu (0.026 mg, 0.27 mmol). Isolated yield = 0.279 g (87%). 1H 
NMR (CDCl3, 500 MHz, 22 °C): δ 9.79 (s, 1H, CArH), 9.30 (d, 1H, JHH = 5.4 Hz; CArH), 8.59 (d, 
1H, JHH = 8.6 Hz; CArH), 8.36 (d, 1H, JHH = 8.4 Hz; CArH), 8.19 (d, 1H, JHH = 7.7 Hz; CArH), 
8.07-7.99 (overlapped m, 2H, CArH), 7.94 (s, 1H, CArH), 7.86-7.78 (m, 2H, CArH), 7.60 (app t, 
1H, JHH = 7.9 Hz; CArH), 7.51-7.44 (overlapped m, 1H, CArH), 7.21 ppm (d, 1H, JHH = 8.0 Hz; 
CArH). 19F{1H} NMR (CDCl3, 470 MHz, 22 °C): δ -62.19 ppm. Anal. Calcd for C23H13ClF3N3Pt: 
C, 44.64; H, 2.12. Found: C, 44.57; H, 2.29. 
2Me,tBu: The general procedure was followed using: L2Me,tBu (0.20 g, 0.58 mmol), Pt(COD)Cl2 
(0.22 g, 0.59 mmol), and NaOtBu (0.06 g, 0.60 mmol). Isolated yield = 0.266 g (79%). 1H NMR 
(CDCl3, 300 MHz, 22 °C): δ 9.60 (s, 1H, 3JPtH = 39 Hz, CArH), 9.17 (d, 1H, JHH = 6.9 Hz; CArH), 
8.59 (d, 1H, JHH = 8.2 Hz; CArH), 8.17 (d, 1H, JHH = 8.4 Hz; CArH), 8.10 (d, 1H, JHH = 7.4 Hz; 
CArH), 7.99-7.89 (overlapped multiplet, 2H, CArH), 7.80 (s, 1H, CArH), 7.72 (app t, 1H, JHH = 6.6 
Hz; CArH), 7.56 (s, 1H, CArH), 7.37 (dd, 1H, JHH = 8.4, 5.2 Hz; CArH), 6.88 (s, 1H, CArH), 2.60 
(s, 3H, CH3), 1.57 ppm (s, 9H, C(CH3)3). Anal. Calcd for C27H24ClN3Pt: C, 52.22; H, 3.90. 
Found: C, 51.91; H, 4.16. 
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2Me,CF3: The general procedure was followed using: L2Me,CF3 (0.21 g, 0.53 mmol), Pt(COD)Cl2 
(0.20 g, 0.53 mmol), and NaOtBu (0.05 g, 0.54 mmol). Isolated yield = 0.222 g (66%). 1H NMR 
(CDCl3, 300 MHz, 22 °C): δ 9.76 (s, 1H, 3JPtH = 39 Hz, CArH), 9.18 (d, 1H, JHH = 5.1 Hz; CArH), 
8.56 (d, 1H, JHH = 8.4 Hz; CArH), 8.23 (d, 1H, JHH = 8.8 Hz; CArH), 8.17 (d, 1H, JHH = 8.0 Hz; 
CArH), 8.08-7.95 (overlapped m, 2H, CArH), 7.91 (s, 1H, CArH), 7.81 (app t, 1H, JHH = 7.6 Hz; 
CArH), 7.58 (s, 1H, CArH), 7.41 (dd, 1H, JHH = 8.3, 5.1 Hz; CArH), 7.00 (s, 1H, CArH), 2.63 ppm 
(s, 3H, CH3). 19F{1H} NMR (CDCl3, 470 MHz, 22 °C): δ -62.49 ppm. Anal. Calcd for 
C24H15ClF3N3Pt: C, 45.54; H, 2.39. Found: C, 45.73; H, 2.41.  
3tBu,tBu: The general procedure was followed using: L3tBu,tBu (0.20 g, 0.41 mmol), Pt(COD)Cl2 
(0.16 g, 0.42 mmol), and NaOtBu (0.04 g, 0.43 mmol). Isolated yield = 0.228 g (78%). 1H NMR 
(CDCl3, 300 MHz, 22 °C): δ 9.63 (s, 2H, CArH), 8.57 (d, 2H, JHH = 8.6 Hz; CArH), 8.11 (d, 2H, 
JHH = 8.0 Hz; CArH), 8.06 (s, 2H, CArH), 7.99-7.88 (m, 2H, CArH), 7.78 (s, 2H, CArH), 7.76-7.66 
(m, 2H, CArH), 1.53 ppm (s, 18H, C(CH3)3). Anal. Calcd for 
C34H32ClN3Pt•(4XCHCl3)(0.5xEt2O): C, 44.08; H, 4.16. Found: C, 44.05, 4.26. 
3CF3,tBu: The general procedure was followed using: L3CF3,tBu (0.20 g, 0.40 mmol),  Pt(COD)Cl2 
(0.15 g, 0.41 mmol), and NaOtBu (0.04 g, 0.42 mmol). Isolated yield = 0.182 g (62%). 1H NMR 
(CDCl3, 300 MHz, 22 °C): δ 9.75 (s, 1H, CArH), 9.58 (s, 1H, CArH), 8.56 (d, 1H, JHH = 8.4 Hz; 
CArH), 8.47 (d, 1H, JHH = 8.4 Hz; CArH), 8.16 (d, 1H, JHH = 7.4 Hz; CArH), 8.10 (d, 1H, JHH = 8.0 
Hz; CArH), 8.03-7.65 (m, 8H, CArH), 1.59 ppm (s, 9H, C(CH3)3). 19F{1H} NMR (CDCl3, 470 
MHz, 22 °C): δ -62.50 ppm. Anal. Calcd for C31H23ClF3N3Pt: C, 51.35; H, 3.20. Found: C, 
51.43; H, 3.21. 
3CF3,CF3: The general procedure was followed using: L3CF3,CF3 (0.28 g, 0.54 mmol), Pt(COD)Cl2 
(0.21g, 0.55 mmol), and NaOtBu (0.05 g, 0.56 mmol). Isolated yield of 3CF3,CF3 = 0.265 g (66%). 
19F{1H} NMR (DMSO, 470 MHz, 22 °C): δ -60.77 ppm. The compound appears to be too 
insoluble to characterize. Anal. Calcd for C28H14ClF3N3Pt(2XCHCl3): C, 36.93; H, 1.65. Found: 
C, 37.224; 1.884. 
X-Ray Crystallography 
X-ray crystal structure data were collected from multi-faceted crystals of suitable size and 
quality selected from a representative sample of crystals of the same habit using an optical 
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microscope. In each case, crystals were mounted on MiTiGen loops and data collection carried 
out in a cold stream of nitrogen (150 K; Bruker D8 QUEST ECO; Mo Kα radiation). All 
diffractometer manipulations were carried out using Bruker APEX3 software.64 Structure 
solution and refinement was carried out using XS, XT and XL software, embedded within the 
Bruker SHELXTL suite.65 For each structure, the absence of additional symmetry was confirmed 
using ADDSYM incorporated in the PLATON program.66 CCDC Nos. 1992330-1992332 
contain the supplementary crystallographic data for this paper. The data can be obtained free of 
charge from The Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/structures. 
 
Crystal structure data for L3CF3,CF3 (CCDC 1992332): X-ray quality crystals were grown from 
reaction mixture in toluene. Crystal structure parameters: C28H15N3F6 507.43 g/mol, monoclinic, 
space group P21/n; a = 13.0578(6) Å, b = 9.2399(4) Å, c = 19.4731(10) Å, α = 90°, β = 
109.319(2)°, γ = 90°, V = 2217.19(18) Å3; Z = 4, ρcalcd = 1.520 g cm−3; crystal dimensions 0.22 x 
0.14 x 0.06 mm3; θmax = 27.525°; 39662 reflections, 3800 independent (Rint = 0.0517), direct 
methods; absorption coeff (µ = 0.126 mm−1), absorption correction semi-empirical from 
equivalents (SADABS); refinement (against Fo2) with SHELXTL V6.1, 334 parameters, 0 
restraints, R1 = 0.0579 (I > 2σ) and wR2 = 0.1518 (all data), Goof = 1.067, residual electron 
density 0.74/−0.55 e Å−3. 
Crystal structure data for 2Me,tBu (CCDC 1992330): X-ray quality crystals were grown following 
diffusion of diethylether vapor into a CHCl3 solution of the compound at room temperature. 
Crystal structure parameters: C27H24Cl1N3Pt1 621.03 g/mol, triclinic, space group P-1; a = 
8.8827(6)Å, b = 11.5775(8)  Å, c = 12.2098(9) Å, α = 63.521(2)°, β = 77.693(2)°, γ = 
88.681(2)°, V = 1094.37(13) Å3; Z = 2, ρcalcd = 1.885 g cm−3; crystal dimensions 0.330 x 0.140 x 
0.040 mm3; θmax = 27.916°; 27804 reflections, 5201 independent (Rint = 0.0288), direct methods; 
absorption coeff (µ = 6.554 mm−1), absorption correction semi-empirical from equivalents 
(SADABS); refinement (against Fo2) with SHELXTL V6.1, 293 parameters, 0 restraints, R1 = 
0.0151 (I > 2σ) and wR2 = 0.0357 (all data), Goof = 1.057, residual electron density 0.909/−0.692 
e Å−3. 
Crystal structure data for 3tBu,tBu (CCDC 1992331): X-ray quality crystals were grown following 
diffusion of diethylether vapor into a CH2Cl2 solution of the compound at room temperature. 
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Crystal structure parameters: C34H26Cl1N3Pt1.CH2Cl2 792.04 g/mol, orthorhombic, space group 
Pnma; a = 24.9983(13) Å, b = 6.7957(3) Å, c = 18.1591(9) Å, α = 90°, β = 90°, γ = 90°, V = 
3084.9(3) Å3; Z = 4, ρcalcd = 1.705 g cm−3; crystal dimensions 0.100 x 0.022 x 0.021 mm3; θmax = 
24.789°; 76058 reflections, 2888 independent (Rint = 0.2484), direct methods; absorption coeff (µ 
= 4.838 mm−1), absorption correction semi-empirical from equivalents (SADABS); refinement 
(against Fo2) with SHELXTL V6.1, 249 parameters, 0 restraints, R1 = 0.0461 (I > 2σ) and wR2 = 
0.0834 (all data), Goof = 1.145, residual electron density 1.273/−0.901 e Å−3. 
Optical Spectroscopy Measurements 
The absorption spectra of the complexes were measured in solution in CH2Cl2 in 1 cm quartz 
cuvettes using a Biotek Instruments XS UV-Visible spectrometer at room temperature.  The 
emission spectra of the proligands at 295 and 77 K, and of their Pt(II) complexes at 77 K, were 
recorded using a Jobin Yvon Fluoromax-2 spectrometer equipped with a red-sensitive 
Hamamatsu R928 photomuliplier tube.  The emission spectra of the Pt(II) complexes at 295 K, 
which extend up to around 1000 nm, were recorded using a thermoelectrically cooled Synapse 
CCD detector, which offers better sensitivity in the red / NIR region compared to the R928 PMT.  
The samples for measurements at 295 K were contained within 1 cm pathlength quartz cuvettes 
modified for attachment to a vacuum line, and were degassed prior to measurement by a 
minimum of three freeze-pump-thaw cycles; final vapor pressure at 77 K was < 10–2 mbar.  
Emission spectra at 77 K were recorded in 4 mm diameter tubes held within a liquid nitrogen 
cooled quartz dewar. Luminescence lifetimes were measured by time-correlated single-photon 
counting (TCSPC) following excitation using a pulsed laser diode at 405 nm; the emitted light 
was detected at right angles to the excitation beam, using an R928 PMT thermoelectrically 
cooled to –20 °C. 
 
Calculations 
DFT optimizations of 2Me,CF3 and 3CF3,CF3 were carried out using Gaussian16, rev. C0167 with 
M06/LANL2DZ68,69 with an IEFPCM70 solvent model with CH2Cl2. TD-DFT and single point 
calculations were performed at the same level of theory. Molecular orbital analyses were carried 
out using the Hirshfeld partition method71 available in Multiwfn software72 and visualized using 
Avogadro.73 TD-DFT results were analyzed using GaussSum.74 Spin density maps were 
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generated using Gabedit.75 To calculate ground-state, excited-state and reorganization energies, 
the following protocol (Figure S40) was followed: (1) The S0 geometry was optimized by 
restricted DFT (charge = 0, multiplicity = 1) using the crystal structure coordinates as starting 
input. The T1 geometry was optimized with unrestricted DFT (charge = 0, multiplicity = 3) using 
the optimized S0 geometry as starting input. Frequency calculations were then subsequently 
carried out to confirm that these structures are at a minimum. (2) To determine the relative 
molecular fragment contributions to the frontier MOs, population analyses were carried out on 
the optimized structures of S0 states (Tables S6 and S7). The electronic energies, E(S0) and 
E(T1), obtained from the single point calculations of S0 and T1 in their respective minimum were 
used to estimate the adiabatic energy (Eadia), where, Eadia = E(T1) – E(S0). (3) TD-DFT was then 
carried out on the first 50 Sn←S0 singlet-singlet transitions with the restricted formalism with 
charge = 0 and multiplicity = 1 to yield Evert-abs. (4) Evert-phos (T1→T1@S0) was estimated as the 
ΔSCF between single point energies of the T1 (charge = 0, multiplicity = 3) and T1@S0 (charge = 
0, multiplicity = 1) both at the optimized T1 geometry. 
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TOC Synopsis 
A series of deep-red emitting Pt(II) phosphors is presented. These charge-neutral complexes 
have the general structure (N^N–^N)PtCl and are supported by benzannulated diarylamido ligand 
scaffolds bearing substituted quinolinyl and/or phenanthridinyl arms. In contradiction to 
conventional assumptions, benzannulation counter-intuitively but markedly blue-shifts emission 
from the metal complexes with identical substitution patterns. This effect can be further tuned by 
incorporation of electron-releasing or electron-withdrawing substituents in either the 
phenanthridine 2-position or quinoline 6-position. 
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